-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROSENSE THERAPEUTICS - ADVANCING DISCUSSIONS WITH COMMERCIALIZATION PARTNERS FOR CANADA

Reuters·11/02/2026 14:07:33